Brooke Flew, Belinda Judd, Belinda Lange, Darren Lee, Felicity Blackstock, Joanna Tai, Kathryn Tognon, Lucy Chipchase
Understanding underperformance in a high-stakes clinical-based simulation assessment in physiotherapy: a descriptive analysis
BMC medical education
assess costs project potential lifetime costeffectiveness ongoing autoimmunity screening kids ask program largescale presymptomatic type 1 diabetes screening program children adolescents metropolitan denver region report resource utilization costs effectiveness measures ongoing ask program compared usual care ie screening additionally report practical screening scenario including utilization costs relevant routine screening clinical practice finally project potential costeffectiveness ask routine screening identifying clinical benchmarks ie diabetic ketoacidosis dka events avoided hba1c improvements vs screening needed meet value thresholds 50000150000 per qualityadjusted lifeyear qaly gained lifetime horizon cost per case detected 4700 ask screening 14000 routine screening achieve value thresholds 50000150000 per qaly gained screening costs would need offset cost savings 20 reductions dka events diagnosis addition 01 11 mmolmol improvements hba1c lifetime compared screening patients develop type 1 diabetes value thresholds met avoiding dka events alone either scenario presymptomatic type 1 diabetes screening may costeffective areas high prevalence dka infrastructure facilitating screening monitoring benefits avoiding dka events improved hba1c persist longrun time horizons data collected ask model updated direct evidence screening effects